We are live on ! Find out more
FG

Foresight Group Portfolio holdings

AUM $556M
1-Year Est. Return 8.6%
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
+8.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$705M
AUM Growth
-$4.53M
Cap. Flow
-$41.6M
Cap. Flow %
-5.91%
Top 10 Hldgs %
41.43%
Holding
64
New
2
Increased
7
Reduced
40
Closed
4

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$8.5M
2
LNTH icon
Lantheus
LNTH
+$6.02M
3
VTR icon
Ventas
VTR
+$2.97M
4
EQIX icon
Equinix
EQIX
+$1.75M
5
CCI icon
Crown Castle
CCI
+$930K

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.07M
2
AMT icon
American Tower
AMT
+$5.73M
3
TEL icon
TE Connectivity
TEL
+$5.4M
4
ECL icon
Ecolab
ECL
+$4.12M
5
A icon
Agilent Technologies
A
+$4.03M

Sector Composition

Rank Sector Weight
1 Healthcare 22.03%
2 Technology 21.71%
3 Real Estate 18.35%
4 Industrials 18.28%
5 Materials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSLR icon
26
First Solar
FSLR
$22.7B
$11.9M 1.69%
72,162
+2,689
+4% +$397K
ICLR icon
27
Icon
ICLR
$12.6B
$11.7M 1.65%
80,202
-670
-0.8% -$95K
ROK icon
28
Rockwell Automation
ROK
$53.4B
$11.5M 1.64%
34,749
-1,012
-3% -$288K
CWEN icon
29
Clearway Energy Class C
CWEN
$4.94B
$11.3M 1.61%
352,713
-9,267
-3% -$277K
DHR icon
30
Danaher
DHR
$137B
$11M 1.55%
55,457
-713
-1% -$138K
VTR icon
31
Ventas
VTR
$48B
$9.99M 1.42%
158,783
+45,484
+40% +$2.97M
GMAB icon
32
Genmab
GMAB
$17.7B
$9.93M 1.41%
48,007
-718
-1% -$14.7K
GMED icon
33
Globus Medical
GMED
$10.7B
$9.54M 1.35%
161,671
-2,192
-1% -$142K
NVO
34
Novo Nordisk
NVO
$208B
$8.64M 1.23%
+124,919
New +$8.5M
DEA
35
Easterly Government Properties
DEA
$1.13B
$8.39M 1.19%
377,423
-27,585
-7% -$602K
CCI icon
36
Crown Castle
CCI
$33.3B
$8.31M 1.18%
82,213
+9,189
+13% +$930K
BEPC icon
37
Brookfield Renewable
BEPC
$6.08B
$7.16M 1.02%
218,400
-8,333
-4% -$243K
APTV icon
38
Aptiv
APTV
$12B
$7.13M 1.01%
104,488
-986
-0.9% -$61.1K
LNTH icon
39
Lantheus
LNTH
$6.49B
$5.61M 0.8%
+68,520
New +$6.02M
PCH
40
DELISTED
PotlatchDeltic
PCH
$2.32M 0.33%
59,504
-8,397
-12% -$330K
WY icon
41
Weyerhaeuser
WY
$18B
$2.27M 0.32%
87,939
-9,447
-10% -$247K
AMH icon
42
American Homes 4 Rent
AMH
$12B
$1.87M 0.27%
51,998
-5,554
-10% -$206K
MAA icon
43
Mid-America Apartment Communities
MAA
$15.4B
$1.56M 0.22%
10,561
-797
-7% -$124K
KRC icon
44
Kilroy Realty
KRC
$4.52B
$1.45M 0.21%
41,767
COLD icon
45
Americold
COLD
$4.02B
$1.39M 0.2%
82,365
PLD icon
46
Prologis
PLD
$135B
$1.39M 0.2%
13,148
-25,701
-66% -$2.7M
ARE icon
47
Alexandria Real Estate Equities
ARE
$8.97B
$1.25M 0.18%
17,055
-4,696
-22% -$349K
STAG icon
48
STAG Industrial
STAG
$7.38B
$1.23M 0.17%
33,905
-32,093
-49% -$1.11M
ADC icon
49
Agree Realty
ADC
$9.34B
$1.22M 0.17%
16,865
PECO icon
50
Phillips Edison & Co
PECO
$5.46B
$1.16M 0.17%
33,307

Similar funds

Foresight Group's Q2 2025 Portfolio in Review

As of Q2 2025, Foresight Group held 64 positions worth $705M, down 0.64% from $709M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foresight Group withdrew a net $41.6M in Q2 2025, closing 4 positions and reducing 40 holdings. Its most notable exit was Cheniere Energy, an estimated $2.59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Foresight Group opened a new position in Novo Nordisk worth $8.64M.

  • Foresight Group's largest Q2 2025 buy was Novo Nordisk: 124,919 shares worth $8.64M.
  • Foresight Group added most to Ventas in Q2 2025, an estimated $2.97M increase.
  • Foresight Group's biggest Q2 2025 reduction was Linde, cutting an estimated $7.07M.
  • Foresight Group fully exited Cheniere Energy in Q2 2025, selling an estimated $2.59M.
  • Foresight Group's ten largest holdings make up 41% of its $705M portfolio in Q2 2025.
  • Foresight Group opened 2 new positions and closed 4 in Q2 2025.
  • Foresight Group's portfolio value fell 0.64% quarter-over-quarter to $705M.

Based on Foresight Group's 13F filing for Q2 2025, filed 13 Aug 2025.